AI Friend or Foe: Global Discussion on the Opportunities and Threats of AI in Healthcare and Life Sciences
October 29 @ 11am – 2pm ET
Share:
11:00 AM
Mihai Diga, Executive, CTO Lifescience
11:15 AM
Samah R Ibrahim, Senior Director, Organon
11:30 AM
Dr. Harsh Shah, Global Director, Commercial Strategy and Value Engineering, Medidata
11:45 AM
Dr. Keith Wharton, Global Medical Affairs, Roche
12:00 PM
Vaibhav Rao, Head of Commercial Excellence and Innovation for Asia, Pfizer
Arun Ravi, Senior Director, Health AI, Microsoft
Ashley Deighan, Director at Mayo Clinic
Chris Huber Reitz, Senior Director, Enterprise AI, Elevance Health
Vlastimil Hrabal, CEO & Co-Founder at KARDI AI
Dr. Stephen Rosenberg, Director of Adaptive Radiotherapy, Moffitt Cancer Center
Loretta Beine, Senior Industry Director, Strategic Business Development, Empire State Development
Gil Bashe, Chair Global Health and Purpose, FINN Partners
Dr. Patrick Wood MD, Coastal Health Practioners
Want to speak, sponsor, or participate more in our events?
Thank you for registering for the event!
Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.